肿瘤标志物研究：泛美1990 - 1995年的经验
Tumor marker study: the Transamerica experience 1990-1995.
作者信息
Elder W J
出版信息
J Insur Med. 1997;29(1):24-9.
PMID:10167692
Abstract
BACKGROUND
From the fall of 1990 through January 1995 Transamerica Occidental Life screened applicants for life insurance for cancer with Tumor Associated Antigen (TAA).
RESULTS
110,299 applicants were tested and in 13,829 positive levels of TAA were found. Of this latter number, 255 applicants were declined following various levels of evaluation.
CONCLUSIONS
We concluded that TAA screening was neither sensitive, nor specific enough for a screening tool for life insurance.
摘要
背景
从1990年秋季到1995年1月，泛美西方人寿保险公司使用肿瘤相关抗原（TAA）对人寿保险申请人进行癌症筛查。
结果
对110,299名申请人进行了检测，发现13,829人的TAA水平呈阳性。在这一数量中，经过不同程度的评估后，有255名申请人被拒保。
结论
我们得出结论，TAA筛查作为一种人寿保险筛查工具，既不够敏感，也不够特异。
Zotero 插件